Zacks Investment ResearchThu, 07 May 2026 13:51:08 GMTAclaris Therapeutics (ACRS) Reports Q1 Loss, Beats Revenue EstimatesACRS+1.44%
Seeking AlphaTue, 28 Apr 2026 18:01:56 GMTAclaris Therapeutics, Inc. (ACRS) Discusses Clinical Program Update and Progress of Lead Bispecific Antibody Candidates TranscriptACRS+1.44%
Zacks Investment ResearchThu, 26 Feb 2026 15:46:29 GMTAclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue EstimatesACRS+1.44%